Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 11.4B | 1.2% |
| Gross Profit | 7.2B | 7.6% |
| Cost of Revenue | 4.24B | 8.1% |
| Operating expense | 7.75B | 43% |
| Net Income | 970M | 67.3% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 75.6B | 5.2% |
| Total Liabilities | 61.4B | 5.2% |
| Total Equity | 14.2B | 5% |
| Shares Outstanding | 901M | 0% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | 3.71B | 153.2% |
| Cash from investing | -4B | 82.1% |
| Cash from financing | 211M | 86.4% |
EPS
Financial Highlights for Eli Lilly and Company in Q3 '24
Eli Lilly and Company reported a revenue of 11.4B, which is a 1.2% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 7.2B, marking a 7.6% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 4.24B, a -8.1% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 7.75B, showing a 43% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 970M, showing a -67.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
Eli Lilly and Company faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
